ISEEK BIOPHARMA, INC Trademark

Trademark Overview

On Sunday, August 13, 2023, a trademark application was filed for ISEEK BIOPHARMA, INC with the United States Patent and Trademark Office. The USPTO has given the ISEEK BIOPHARMA, INC trademark a serial number of 98130381. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, May 12, 2025. The ISEEK BIOPHARMA, INC trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development
iseek biopharma, inc

General Information

Serial Number98130381
Word MarkISEEK BIOPHARMA, INC
Filing DateSunday, August 13, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, May 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 17, 2024

Trademark Statements

NOT AVAILABLE"BIOPHARMA, INC"
Goods and ServicesPharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 12, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressAlbuquerque, NM 871116602
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressAlbuquerque, NM 871116602

Trademark Events

Event DateEvent Description
Wednesday, August 16, 2023NEW APPLICATION ENTERED
Tuesday, September 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 12, 2024ASSIGNED TO EXAMINER
Tuesday, April 23, 2024NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, April 23, 2024COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Tuesday, April 23, 2024EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, April 23, 2024EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Tuesday, July 23, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 23, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 23, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 15, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 17, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 17, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, May 12, 2025SOU TEAS EXTENSION RECEIVED
Monday, May 12, 2025SOU EXTENSION 1 FILED
Tuesday, May 13, 2025SOU EXTENSION 1 GRANTED
Tuesday, May 13, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 12, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

biopharma iseek development research pharmaceutical